financetom
Business
financetom
/
Business
/
Applied Materials Q3 Earnings: Revenue Beat, EPS Beat, Demand Being Driven By 'Race For AI Leadership' And More
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Applied Materials Q3 Earnings: Revenue Beat, EPS Beat, Demand Being Driven By 'Race For AI Leadership' And More
Aug 15, 2024 2:05 PM

Applied Materials Inc ( AMAT ) reported third-quarter financial results after the market close on Thursday. Here’s a rundown of the report.

Q3 Earnings: Applied Materials ( AMAT ) reported third-quarter revenue of $6.78 billion, beating the consensus estimate of $6.673 billion. The chip equipment company reported adjusted earnings of $2.12 per share, beating analyst estimates of 2.02 per share.

Applied Materials ( AMAT ) has now exceeded analyst estimates for revenue and EPS in nine consecutive quarters, according to historical data from Benzinga Pro.

Total revenue was up 5% year-over-year. Applied Materials ( AMAT ) said it generated $2.39 billion in cash from operations and distributed $1.19 billion to shareholders including $861 million in share repurchases and $331 million in dividends. The company ended the quarter with $8.288 billion in cash and cash equivalents.

“Applied Materials is delivering strong results in 2024 with record revenues in our fiscal third quarter and earnings towards the high end of our guided range,” said Gary Dickerson, president and CEO of Applied Materials ( AMAT ).

“The race for AI leadership is fueling demand for our unique and connected portfolio of products and services, positioning Applied to outperform our markets over the longer term.”

See Also: EXCLUSIVE: Which Magnificent 7 Stock Would Investors Put $1,000 In Today? 44% Of Benzinga Readers Pick This Company

Q4 Guidance: Applied Materials ( AMAT ) anticipates fourth-quarter revenue of $6.53 billion, plus or minus $400 million, versus estimates of $6.91 billion. The company expects fourth-quarter adjusted earnings to be between $2 and $2.36 per share, versus estimates of $2.14 per share. 

Applied Materials’ management team will hold a conference call at 4:30 p.m. ET to further discuss its quarterly performance.

AMAT Price Action: Applied Materials ( AMAT ) shares were down 0.72% in after-hours, trading at $209.68 at the time of publication, according to Benzinga Pro.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tandem Diabetes Care Plans $250 Million Private Placement Notes -- Shares Decline After Hours
Tandem Diabetes Care Plans $250 Million Private Placement Notes -- Shares Decline After Hours
Mar 4, 2024
05:31 PM EST, 03/04/2024 (MT Newswires) -- Tandem Diabetes Care ( TNDM ) said Monday it plans a private placement of $250 million in principal amount of convertible notes due 2029. Initial purchasers will have the option to buy up to an additional $37.5 million principal amount of notes, according to the company. Net proceeds, along with cash at hand,...
BRIEF-Bowflex Inc Says Co Files For Voluntary Chapter 11 Protection & Reaches Stalking Horse Agreement To Facilitate Sale
BRIEF-Bowflex Inc Says Co Files For Voluntary Chapter 11 Protection & Reaches Stalking Horse Agreement To Facilitate Sale
Mar 4, 2024
March 5 (Reuters) - BowFlex Inc ( BFX ): * BOWFLEX INC. ( BFX ) FILES FOR VOLUNTARY CHAPTER 11 PROTECTION AND REACHES STALKING HORSE AGREEMENT TO FACILITATE SALE * BOWFLEX ( BFX ) - SECURED COMMITMENT FOR $25 MILLION IN DIP FINANCING TO CONTINUE TO FULFILL CUSTOMER ORDERS AND SUPPORT ORDINARY COURSE OPERATIONS * BOWFLEX ( BFX ) :...
BRIEF-Telix To Acquire ARTMS Inc And Its Advanced Isotope Production Platform
BRIEF-Telix To Acquire ARTMS Inc And Its Advanced Isotope Production Platform
Mar 4, 2024
March 4 (Reuters) - Telix Pharmaceuticals Ltd ( TLPPF ): * TELIX TO ACQUIRE ARTMS, INC. AND ITS ADVANCED ISOTOPE PRODUCTION PLATFORM * TELIX PHARMACEUTICALS LTD ( TLPPF ) - ACQUISITION HAS POTENTIAL TO BE FINANCIALLY ACCRETIVE, ADD ADDITIONAL REVENUE * TELIX PHARMACEUTICALS LTD ( TLPPF ) - ACQUISITION HAS POTENTIAL TO HAVE POSITIVE IMPACT ON GROSS MARGINS FOR ILLUCCIX...
PRESS DIGEST- Financial Times - March 5
PRESS DIGEST- Financial Times - March 5
Mar 4, 2024
March 5 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines - Cinven agrees to buy majority stake in fund administrator Alter Domus - Jeremy Hunt set to give motorists 5 bln pound tax break in the Budget - 'Erroneous' filings highlight flaws...
Copyright 2023-2025 - www.financetom.com All Rights Reserved